• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶的抑制作用:机制及底物依赖性

Inhibition of angiotensin converting enzyme: mechanism and substrate dependence.

作者信息

Shapiro R, Riordan J F

出版信息

Biochemistry. 1984 Oct 23;23(22):5225-33. doi: 10.1021/bi00317a021.

DOI:10.1021/bi00317a021
PMID:6095893
Abstract

The interaction of angiotensin converting enzyme with six metal-coordinating [(D-3-mercapto-2-methylpropanoyl)-L-Pro (captopril), N-[1(S)-carboxy-3-phenylpropyl]-L-Ala-L-Pro (MK-422), N-(phenylphosphoryl)-L-Phe-L-Phe, N alpha-(3-mercaptopropanoyl)-L-Arg, N alpha-[1(S)-carboxy-3-phenylpropyl]-Ala-L-Lys, and N-[1(S)-carboxy-5-aminopentyl]-L-Phe-Gly] and three dipeptide inhibitors (Gly-L-Trp, L-Phe-L-Arg, and L-Ala-L-Pro) was examined at pH 7.5 in the presence of 300 mM NaCl. Inhibition modes, apparent Ki [Ki(app)] values, and shapes of 1/v vs. [I] plots were found to vary with the substrate employed. All inhibitors except Phe-Arg were competitive with the substrate furanacryloyl (Fa)-Phe-Gly-Gly, while five of seven tested with Fa-Phe-Phe-Arg as substrate produced mixed patterns. Ki-(app) values for N-[1(S)-carboxy-5-aminopentyl]-L-Phe-Gly, N-(phenylphosphoryl)-L-Phe-L-Phe, Gly-Trp, and MK-422 were 8.3-, 5.5-, 4.7-, and 2.6-fold lower, respectively, when Fa-Phe-Gly-Gly was substrate, compared with values measured with Fa-Phe-Phe-Arg. In contrast, Ki(app) values for Phe-Arg and (3-mercaptopropanoyl)-Arg were lower (2.8- and 2.2-fold, respectively) when Fa-Phe-Phe-Arg was the substrate. Plots of 1/v vs. [I] for most of the inhibitors were nonlinear, to an extent which was also substrate dependent.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在300 mM氯化钠存在的情况下,于pH 7.5条件下检测了血管紧张素转换酶与六种金属配位抑制剂[(D-3-巯基-2-甲基丙酰基)-L-脯氨酸(卡托普利)、N-[1(S)-羧基-3-苯基丙基]-L-丙氨酸-L-脯氨酸(MK-422)、N-(苯基磷酰基)-L-苯丙氨酸-L-苯丙氨酸、Nα-(3-巯基丙酰基)-L-精氨酸、Nα-[1(S)-羧基-3-苯基丙基]-丙氨酸-L-赖氨酸和N-[1(S)-羧基-5-氨基戊基]-L-苯丙氨酸-甘氨酸]以及三种二肽抑制剂(甘氨酸-L-色氨酸、L-苯丙氨酸-L-精氨酸和L-丙氨酸-L-脯氨酸)的相互作用。发现抑制模式、表观Ki[Ki(app)]值以及1/v对[I]的曲线形状随所使用的底物而变化。除苯丙氨酸-精氨酸外,所有抑制剂与底物呋喃丙烯酰基(Fa)-苯丙氨酸-甘氨酸-甘氨酸均呈竞争性,而以Fa-苯丙氨酸-苯丙氨酸-精氨酸作为底物进行测试的七种抑制剂中有五种呈现混合模式。当Fa-苯丙氨酸-甘氨酸-甘氨酸作为底物时,N-[1(S)-羧基-5-氨基戊基]-L-苯丙氨酸-甘氨酸、N-(苯基磷酰基)-L-苯丙氨酸-L-苯丙氨酸、甘氨酸-色氨酸和MK-422的Ki(app)值分别比以Fa-苯丙氨酸-苯丙氨酸-精氨酸作为底物时测得的值低8.3倍、5.5倍、4.7倍和2.6倍。相反,当Fa-苯丙氨酸-苯丙氨酸-精氨酸作为底物时,苯丙氨酸-精氨酸和(3-巯基丙酰基)-精氨酸的Ki(app)值更低(分别为2.8倍和2.2倍)。大多数抑制剂的1/v对[I]的曲线是非线性的,其非线性程度也取决于底物。(摘要截短于250字)

相似文献

1
Inhibition of angiotensin converting enzyme: mechanism and substrate dependence.血管紧张素转换酶的抑制作用:机制及底物依赖性
Biochemistry. 1984 Oct 23;23(22):5225-33. doi: 10.1021/bi00317a021.
2
Inhibition of angiotensin converting enzyme: dependence on chloride.
Biochemistry. 1984 Oct 23;23(22):5234-40. doi: 10.1021/bi00317a022.
3
Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.Nα-[(S)-1-羧基-3-苯基丙基] -L-丙氨酰-L-脯氨酸和Nα-[(S)-1-羧基-3-苯基丙基] -L-赖氨酰-L-脯氨酸对兔肺血管紧张素转换酶的抑制作用
J Biol Chem. 1985 Mar 10;260(5):2952-62.
4
Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.2-[N-[(S)-1-羧基-3-苯基丙基]-L-丙氨酰]-(1S,3S,5S)-2-氮杂双环[3.3.0]辛烷-3-羧酸(Hoe 498二酸)对血管紧张素转换酶的抑制作用。与卡托普利和依那普利拉的比较。
Arzneimittelforschung. 1984;34(10B):1406-10.
5
Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.牛体细胞血管紧张素转换酶中两个活性位点负协同性的证据。
FEBS Lett. 2003 Aug 28;550(1-3):84-8. doi: 10.1016/s0014-5793(03)00825-1.
6
Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups: captopril and SA 446.
Clin Sci (Lond). 1981 Dec;61 Suppl 7:277s-280s. doi: 10.1042/cs061277s.
7
An angiotensin converting enzyme inhibitor is a tight-binding slow substrate of carboxypeptidase A.血管紧张素转换酶抑制剂是羧肽酶A的一种紧密结合的慢底物。
J Inorg Biochem. 1989 May;36(1):39-50. doi: 10.1016/0162-0134(89)80011-x.
8
Mapping the active site of angiotensin-converting enzyme by transferred NOE spectroscopy.通过转移核Overhauser效应光谱法绘制血管紧张素转换酶的活性位点
J Med Chem. 2000 Jun 1;43(11):2093-9. doi: 10.1021/jm990194x.
9
The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.神经肽的代谢。肽的水解,包括脑啡肽、速激肽及其类似物,由内肽酶-24.11进行。
Biochem J. 1984 Oct 15;223(2):433-40. doi: 10.1042/bj2230433.
10
Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.N-[(S)-1-羧基-3-苯基丙基]-L-丙氨酰-L-脯氨酸及其乙酯(MK-421)对体外血管紧张素转换酶及体内血管紧张素I升压反应的影响。
J Pharmacol Exp Ther. 1981 Mar;216(3):552-7.

引用本文的文献

1
ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.ACE2 和 ACE:基于结构的 SARS-CoV 机制、调控和受体识别的见解。
Clin Sci (Lond). 2020 Nov 13;134(21):2851-2871. doi: 10.1042/CS20200899.
2
Computer-aided lead optimization: improved small-molecule inhibitor of the zinc endopeptidase of botulinum neurotoxin serotype A.计算机辅助先导化合物优化:新型肉毒梭菌神经毒素 A 型锌内肽酶小分子抑制剂。
PLoS One. 2007 Aug 22;2(8):e761. doi: 10.1371/journal.pone.0000761.
3
Phosphonium compounds as new and specific inhibitors of bovine serum amine oxidase.
鏻化合物作为牛血清胺氧化酶的新型特异性抑制剂。
Biochem J. 2004 Dec 15;384(Pt 3):551-8. doi: 10.1042/BJ20031883.
4
Polymorphic inhibition of human angiotensin I-converting enzyme by enalaprilat.依那普利拉对人血管紧张素I转换酶的多态性抑制作用
Eur J Clin Pharmacol. 1995;49(3):173-5. doi: 10.1007/BF00192376.
5
Binding to thermolysin of phenolate-containing inhibitors necessitates a revised mechanism of catalysis.含酚盐抑制剂与嗜热菌蛋白酶的结合需要一种修正的催化机制。
Biochem J. 1994 Aug 15;302 ( Pt 1)(Pt 1):57-68. doi: 10.1042/bj3020057.
6
Perindopril. A review of its pharmacokinetics and clinical pharmacology.培哚普利。其药代动力学与临床药理学综述。
Drugs. 1990;39 Suppl 1:49-63. doi: 10.2165/00003495-199000391-00009.
7
Effect of temperature and chloride on steady-state inhibition of angiotensin I-converting enzyme by enalaprilat and ramiprilat.温度和氯离子对依那普利拉和雷米普利拉对血管紧张素I转换酶稳态抑制的影响。
Biochem J. 1990 Dec 1;272(2):415-9. doi: 10.1042/bj2720415.
8
Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.雷米普利。对其药理特性及在心血管疾病中的治疗效果的综述。
Drugs. 1990 Jan;39(1):110-35. doi: 10.2165/00003495-199039010-00009.
9
Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.组织和血浆血管紧张素转换酶以及对血管紧张素转换酶抑制剂药物的反应。
Br J Clin Pharmacol. 1991 Jan;31(1):1-13. doi: 10.1111/j.1365-2125.1991.tb03851.x.